How has the treatment outcomes for advanced renal cell carcinomalmproved in the 10 years after approval of targeted therapy ?

Kenjiro Imada, Masatoshi Eto

Surgery

Research output: Contribution to journal › Article

Original language	English
Pages (from-to)	40-44
Number of pages	5
Journal	Japanese Journal of Cancer and Chemotherapy
Volume	46
Issue number	1
Publication status	Published - Jan 2019

All Science Journal Classification (ASJC) codes

Oncology
Cancer Research

Access to Document

Cite this

Imada, K., & Eto, M. (2019). How has the treatment outcomes for advanced renal cell carcinomalmproved in the 10 years after approval of targeted therapy ? Japanese Journal of Cancer and Chemotherapy, 46(1), 40-44.

@article{927ec565e4c34fc18312db1e52abe021,

title = "How has the treatment outcomes for advanced renal cell carcinomalmproved in the 10 years after approval of targeted therapy ?",

author = "Kenjiro Imada and Masatoshi Eto",

year = "2019",

month = jan,

language = "English",

volume = "46",

pages = "40--44",

journal = "Japanese Journal of Cancer and Chemotherapy",

issn = "0385-0684",

publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",

number = "1",

}

TY - JOUR

T1 - How has the treatment outcomes for advanced renal cell carcinomalmproved in the 10 years after approval of targeted therapy ?

AU - Imada, Kenjiro

AU - Eto, Masatoshi

PY - 2019/1

Y1 - 2019/1

UR - http://www.scopus.com/inward/record.url?scp=85061569472&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061569472&partnerID=8YFLogxK

M3 - Article

C2 - 30765640

AN - SCOPUS:85061569472

VL - 46

SP - 40

EP - 44

JO - Japanese Journal of Cancer and Chemotherapy

JF - Japanese Journal of Cancer and Chemotherapy

SN - 0385-0684

IS - 1

ER -